Research

Pharmaceutical Sciences

Title :

Structure-based design of novel peptidomimetics targeting the SARS-CoV-2 spike protein

Area of research :

Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences

Focus area :

Repurposing therapeutics for COVID-19

Principal Investigator :

Dr Mirza S Baig, Associate Professor, Indian Institute of Technology (IIT) Indore

Timeline Start Year :

2020

Contact info :

Details

Organizations involved

Implementing Agency :

Indian Institute of Technology (IIT) Indore

Related Research

A clinical drug development programme to evaluate and compare the safety and efficacy of new regimens of Lifecare's Liposomal Amphotericin b (FUNGISOMETM) against currently accepted therapies for the treatment of Kala Azar; A Phase III, Open Label Randomized Trial of Three Single Dose Treatment regimens of FUNGISOMETM ALONE OR IN Combination with Miltefosine compared with single Dose Treatment regimen of AmBisome for visceral Leishmaniasis in India
pH-Responsive Biodegradable Nanogels for Controlled and Targeted Drug Delivery Systems
International Network Research Project on "Stopping Covid-19 pandemic"
Re-purposing of FDA drugs and exploitation of ancient Ayurvedic knowledge to discover novel inhibitors to block coronavirus propagation
Development of affordable synthetic route of Re-purposed small molecule drugs for the treatment of SARS-CoV-2